申请人:ELI LILLY AND COMPANY
公开号:EP0373836A1
公开(公告)日:1990-06-20
The present invention provides propanamines, substituted at the 3-position of the propanamine chain with a thio, sulfinyl or sulfonyl moiety, of the formula
wherein:
R is phenyl, substituted phenyl, naphthyl, substituted naphthyl, thienyl, halothienyl, (C₁-C₄ alkyl)-substituted-thienyl, furanyl, halofuranyl, (C₁-C₄ alkyl)-substituted-furanyl, pyrrolyl, halopyrrolyl or (C₁-C₄ alkyl)-substituted-pyrrolyl;
R¹ is phenyl, substituted phenyl, C₅-C₇ cycloalkyl, thienyl, halothienyl, (C₁-C₄ alkyl)-substituted-thienyl, furanyl, pyridyl or thiazolyl;
R² and R³ are each independently hydrogen or methyl;
n is 0, 1 or 2; and
the pharmaceutically acceptable acid addition salts thereof.
They are capable of selectively inhibiting the uptake of serotonin and norepinephrine.
本发明提供了在丙胺链的 3 位被硫基、亚砜基或磺酰基取代的丙胺,其式为
其中
R 是苯基、取代的苯基、萘基、取代的萘基、噻吩基、卤代噻吩基、(C₁-C₄烷基)-取代的噻吩基、呋喃基、卤代呋喃基、(C₁-C₄烷基)-取代的呋喃基、吡咯基、卤代吡咯基或(C₁-C₄烷基)-取代的吡咯基;
R¹ 是苯基、取代苯基、C₅-C₇ 环烷基、噻吩基、卤代噻吩基、(C₁-C₄ 烷基)-取代噻吩基、呋喃基、吡啶基或噻唑基;
R² 和 R³ 各自独立地为氢或甲基;
n 是 0、1 或 2;以及
其药学上可接受的酸加成盐。
它们能够选择性地抑制血清素和去甲肾上腺素的摄取。